4-imino-3-(4-methoxyphenyl)-8,8-dimethyl-5-phenyl-5,7,8,9-tetrahydro-3H-chromeno[2,3-d]pyrimidin-6(4H)-one

ID: ALA5280034

Chembl Id: CHEMBL5280034

Max Phase: Preclinical

Molecular Formula: C26H25N3O3

Molecular Weight: 427.50

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2cnc3c(c2=N)C(c2ccccc2)C2=C(CC(C)(C)CC2=O)O3)cc1

Standard InChI:  InChI=1S/C26H25N3O3/c1-26(2)13-19(30)22-20(14-26)32-25-23(21(22)16-7-5-4-6-8-16)24(27)29(15-28-25)17-9-11-18(31-3)12-10-17/h4-12,15,21,27H,13-14H2,1-3H3

Standard InChI Key:  ZDXNJTLKVLSBGG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5280034

    ---

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PPO2 Tyrosinase (3884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.50Molecular Weight (Monoisotopic): 427.1896AlogP: 4.53#Rotatable Bonds: 3
Polar Surface Area: 77.20Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.32CX LogP: 4.12CX LogD: 4.09
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.67Np Likeness Score: -0.55

References

1. Elattar KM, El-Khateeb AY, Hamed SE..  (2022)  Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.,  13  (5.0): [PMID:35694689] [10.1039/d2md00076h]

Source